Angiotensin-Converting Enzyme 3D structures: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 24: | Line 24: | ||
**[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE 1 + chronic heart failure drug<br /> | **[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE 1 + chronic heart failure drug<br /> | ||
**[[7e7e]] - hANCE 2 + antibody<br /> | **[[7e7e]] - hANCE 2 + antibody<br /> | ||
**[[7v61]] – hANCE 2 + Na-dependent neutral amino acid | **[[7v61]] – hANCE 2 + Na-dependent neutral amino acid transporter + 3E8 – Cryo EM<br /> | ||
transporter + 3E8 – Cryo EM<br /> | |||
**[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE 1 + phosphinic inhibitor<br /> | **[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE 1 + phosphinic inhibitor<br /> | ||
**[[4ca6]], [[6tt1]] - hANCE 1 (mutant) + phosphinic inhibitor<br /> | **[[4ca6]], [[6tt1]] - hANCE 1 (mutant) + phosphinic inhibitor<br /> |